02/09/2025
We’re delighted to have helped Benchmark Holdings PLC with its most recent corporate actions, including the production and mailing of shareholder documentation for the disposal of its genetics business, return of capital to shareholders, tender offer, and de-listing from AIM and Euronext Growth Oslo prior to re-registering as a private company.
Following the disposal of the Group's Genetics Business, which completed on 31 March 2025, the Company - in consultation with major shareholders - assessed how best to return excess capital to shareholders and position the remaining operating businesses for future growth. Accordingly, the Company today announces a series of inter-conditional corporate actions including:
- the return of the vast majority of the net proceeds from the disposal back to Shareholders via a combination of a Tender Offer and a planned special dividend;
- cancellation of the Company's Ordinary Shares on AIM and Euronext Oslo Growth due to the cost, management resource and regulatory burden associated with maintaining the admissions; and
- re-registering as a private company with an appropriate level of working and development/growth capital for the Group's residual operating businesses and implementation of management's existing near to medium term business plan.
It’s been a pleasure working with Benchmark Holdings, from their corporate actions to their corporate reporting, alongside advisors DLA Piper. We wish the Benchmark team every success in their future as a private company.
If you'd like to find out how we can help ensure the success of your most critical M&A transactions and corporate actions, chat with us today: hello@blackandcallow.com
